Table 1.
Characteristics of the study population.
Table 2.
Description of PXE patients with proved or suspected coronary artery disease.
Table 3.
Systolic and diastolic LV function.
Table 4.
Valve anomalies.
Figure 1.
Echocardiographic data from Abcc6−/− and wild type mice.
LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; AWd, diastolic anterior wall thickness; AWs, systolic anterior wall thickness; PWd, diastolic posterior wall thickness; PWs, systolic posterior wall thickness; LVSF, left ventricular shortening fraction. WT 12 months, 12-month-old wild type mice (n = 11); Abcc6−/− 12 months, 12-month-old Abcc6−/− mice (n = 9); WT 24 months, 24-month-old WT mice (n = 5); Abcc6−/− 24 months, 24-month-old Abcc6−/− mice (n = 5). Data is expressed as mean ± SEM.
Figure 2.
Data is expressed as mean ± SEM.
Figure 3.
Cardiomyocyte cross-sectional area measurements.
Tabulated data and representative pictures from WGA-FITC staining. All data is expressed as mean ± SEM.
Figure 4.
Tabulated data and representative pictures from picrosirius red staining. Data is expressed as mean ± SEM.